Dennis C. Copertino Jr
www.bradjoneslab.org
0000-0002-3217-4713
Weill Cornell Medicine
3 papers found
Refreshing results…
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial
Missing publications? Search for publications with a matching author name.